WuXi PharmaTech Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Evergrande Stock Suspended Amid Default Concerns; Sending Futures, Cryptos Sliding
Article By: Tyler Durden
Monday, October 4, 2021 12:30 AM EST
Asian markets are discombobulated Monday morning as trading in Evergrande and its property management unit were suspended in Hong Kong. Asian stocks also get their first chance to react to Friday's Merck news.
In this article: WX, EGRNF, ALBHF
Read
Week In Review: Suzhou's MabSpace Raises $15 Million For Antibody Program
Article By: ChinaBio® Today
Saturday, October 31, 2015 1:39 PM EST
WuXi PharmaTech has formed a partnership with Gilead Sciences under which WuXi will equip and operate a dedicated lab in Shanghai for Gilead's small-molecule new chemical entities.
In this article: LLY, WX, SVA
Read
Week In Review: Beijing's Beigene Plans $100 Million IPO In The US
Article By: ChinaBio® Today
Saturday, October 24, 2015 12:01 PM EST
Beigene, a Beijing biopharma, filed to raise $100 million in a US IPO. The company develops novel, molecularly targeted and immuno-oncology drugs to treat cancer.
In this article: LLY, WX, ABBV
Read
Week In Review: Innovent And Lilly Sign $1 Billion Cancer Deal
Article By: ChinaBio® Today
Sunday, October 18, 2015 10:58 PM EST
Innovent Biologics of Suzhou and Eli Lilly expanded their 10-year collaboration formed in March this year, granting Lilly ex-China rights to three new anti-PD-1 cancer drugs developed by Innovent.
In this article: LLY, WX, HCM
Read
Week In Review: Roche Buys China-Backed GeneWEAVE For $425 Million
Article By: ChinaBio® Today
Sunday, August 16, 2015 3:41 AM EST
Roche will pay $190 million up front and up to $235 million in milestones. GeneWEAVE’s Smarticles technology develops innovative molecular diagnostics that identify multidrug-resistant organisms.
In this article: RHHBY, WX
Read

Latest Tweets for $WX

No tweets yet!

PARTNER HEADLINES